News

Moderna Pulls Promising Covid-Flu Combo Shot as RFK Continues Antivax Campaign
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
BioSpace3d
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy ...
Monthly Prescribing Reference6d
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The vaccine is expected to be commercially ready for the 2025-2026 COVID-19 season. The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active ...
pharmaphorum25d
FDA approves fast tests for coronavirus as US faces shortages
The FDA has approved two fast tests for the coronavirus that is causing the COVID-19 epidemic, which are able to produce results within hours instead of days. Testing for the SARS-CoV-2 ...
Reading Eagle26d
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
Because the coronavirus ... from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines. The FDA was on track to grant Novavax full approval by ...
The Associated Press on MSN17d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...